Goldman Sachs’s Cardiovascular Systems, Inc. CSII Stock Holding History

Goldman Sachs’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-26,000	Closed	-$732K	–	6746
2017 Q3	$732K	Buy	+26,000	New	+$791K	﹤0.01%	4827
2014 Q3	–	Sell	-30,000	Closed	-$935K	–	7311
2014 Q2	$935K	Hold	30,000	–	–	﹤0.01%	4752
2014 Q1	$954K	Buy	+30,000	New	+$991K	﹤0.01%	4717

Other funds holding CSII

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Goldman Sachs's CSII Position: Q2 2023 in Review

Goldman Sachs sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 582,424 shares — an estimated $11.6M sold.

Goldman Sachs first reported a position in CSII in Q4 2013 and held it in 33 quarters. The position peaked at $12.5M in Q1 2020. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

Goldman Sachs reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 582,424 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $11.6M.
Goldman Sachs first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 33 quarters.
Goldman Sachs's Cardiovascular Systems, Inc. position peaked at $12.5M in Q1 2020.
2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.